{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T03:26:37Z","timestamp":1790047597472,"version":"4.0.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"22","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T00:00:00Z","timestamp":1598832000000},"content-version":"vor","delay-in-days":1187,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81372138"],"award-info":[{"award-number":["81372138"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81572384"],"award-info":[{"award-number":["81572384"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81472543"],"award-info":[{"award-number":["81472543"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National key Research & Development Project of China","award":["2016YFC1303401"],"award-info":[{"award-number":["2016YFC1303401"]}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1074\/jbc.m117.783365","type":"journal-article","created":{"date-parts":[[2017,4,15]],"date-time":"2017-04-15T00:20:09Z","timestamp":1492215609000},"page":"9136-9149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Physical interaction between human ribonucleotide reductase large subunit and thioredoxin increases colorectal cancer malignancy"],"prefix":"10.1016","volume":"292","author":[{"given":"Meng","family":"Lou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoping","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiling","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueping","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongfeng","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghui","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimin","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.M117.783365_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1570-9639(04)00054-8","article-title":"Structure, function, and mechanism of ribonucleotide reductases","volume":"1699","author":"Kolberg","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1074\/jbc.M117.783365_bib2","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1146\/annurev.biochem.75.103004.142443","article-title":"Ribonucleotide reductases","volume":"75","author":"Nordlund","year":"2006","journal-title":"Annu. Rev. Biochem"},{"key":"10.1074\/jbc.M117.783365_bib3","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.str.2016.05.006","article-title":"The most interesting enzyme in the world","volume":"24","author":"Mathews","year":"2016","journal-title":"Structure"},{"key":"10.1074\/jbc.M117.783365_bib4","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1517\/14728222.2013.840293","article-title":"Targeting ribonucleotide reductase for cancer therapy","volume":"17","author":"Shao","year":"2013","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1074\/jbc.M117.783365_bib5","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3109\/10409238.2011.630372","article-title":"DNA building blocks: keeping control of manufacture","volume":"47","author":"Hofer","year":"2012","journal-title":"Crit. Rev. Biochem. Mol. Biol"},{"key":"10.1074\/jbc.M117.783365_bib6","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1038\/onc.2014.155","article-title":"Ribonucleotide reductase and cancer: biological mechanisms and targeted therapies","volume":"34","author":"Aye","year":"2015","journal-title":"Oncogene"},{"key":"10.1074\/jbc.M117.783365_bib7","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S1470-2045(10)70244-8","article-title":"The ribonucleotide reductase large subunit (RRM1) as a predictive factor in patients with cancer","volume":"12","author":"Jordheim","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1074\/jbc.M117.783365_bib8","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1200\/JCO.2004.12.002","article-title":"RRM1 and PTEN as prognostic parameters for overall and disease-free survival in patients with non-small-cell lung cancer","volume":"22","author":"Bepler","year":"2004","journal-title":"J. Clin. Oncol"},{"key":"10.1074\/jbc.M117.783365_bib9","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1007\/s13277-015-3137-4","article-title":"Non-enzymatic action of RRM1 protein upregulates PTEN leading to inhibition of colorectal cancer metastasis","volume":"36","author":"Qi","year":"2015","journal-title":"Tumour Biol"},{"key":"10.1074\/jbc.M117.783365_bib10","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.lungcan.2010.02.005","article-title":"The immunohistochemical overexpression of ribonucleotide reductase regulatory subunit M1 (RRM1) protein is a predictor of shorter survival to gemcitabine-based chemotherapy in advanced non-small cell lung cancer (NSCLC)","volume":"70","author":"Lee","year":"2010","journal-title":"Lung Cancer"},{"key":"10.1074\/jbc.M117.783365_bib11","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2174\/156800906777723949","article-title":"Ribonucleotide reductase inhibitors and future drug design","volume":"6","author":"Shao","year":"2006","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1074\/jbc.M117.783365_bib12","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.freeradbiomed.2013.07.036","article-title":"The thioredoxin antioxidant system","volume":"66","author":"Lu","year":"2014","journal-title":"Free Radic. Biol. Med"},{"key":"10.1074\/jbc.M117.783365_bib13","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1146\/annurev.biophys.30.1.421","article-title":"Properties and biological activities of thioredoxins","volume":"30","author":"Powis","year":"2001","journal-title":"Annu. Rev. Biophys. Biomol. Struct"},{"key":"10.1074\/jbc.M117.783365_bib14","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1089\/ars.2010.3114","article-title":"Structure, function, and mechanism of thioredoxin proteins","volume":"13","author":"Collet","year":"2010","journal-title":"Antioxid. Redox Signal"},{"key":"10.1074\/jbc.M117.783365_bib15","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1089\/ars.2006.8.2143","article-title":"Role of thioredoxin in cell growth through interactions with signaling molecules","volume":"8","author":"Yoshioka","year":"2006","journal-title":"Antioxid. Redox Signal"},{"key":"10.1074\/jbc.M117.783365_bib16","doi-asserted-by":"crossref","first-page":"21890","DOI":"10.1074\/jbc.M801047200","article-title":"Regulation of the catalytic activity and structure of human thioredoxin 1 via oxidation and S-nitrosylation of cysteine residues","volume":"283","author":"Hashemy","year":"2008","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M117.783365_bib17","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0006-291X(03)00993-8","article-title":"Increased thioredoxin-1 inhibits SSAT expression in MCF-7 human breast cancer cells","volume":"306","author":"Husbeck","year":"2003","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1074\/jbc.M117.783365_bib18","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.semcancer.2006.09.005","article-title":"Thioredoxin in cancer\u2014role of histone deacetylase inhibitors","volume":"16","author":"Marks","year":"2006","journal-title":"Semin. Cancer Biol"},{"key":"10.1074\/jbc.M117.783365_bib19","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1073\/pnas.0611095104","article-title":"Role of the C terminus of the ribonucleotide reductase large subunit in enzyme regeneration and its inhibition by Sml1","volume":"104","author":"Zhang","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M117.783365_bib20","doi-asserted-by":"crossref","first-page":"6905","DOI":"10.1021\/bi00396a006","article-title":"Location of the redox-active thiols of ribonucleotide reductase: sequence similarity between the Escherichia coli and Lactobacillus leichmannii enzymes","volume":"26","author":"Lin","year":"1987","journal-title":"Biochemistry"},{"key":"10.1074\/jbc.M117.783365_bib21","doi-asserted-by":"crossref","first-page":"12249","DOI":"10.1016\/S0021-9258(18)63849-9","article-title":"Evidence for two different classes of redox-active cysteines in ribonucleotide reductase of Escherichia coli","volume":"264","author":"Aberg","year":"1989","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M117.783365_bib22","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.freeradbiomed.2010.09.005","article-title":"The use of thiols by ribonucleotide reductase","volume":"49","author":"Holmgren","year":"2010","journal-title":"Free Radic. Biol. Med"},{"key":"10.1074\/jbc.M117.783365_bib23","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4331\/wjbc.v5.i1.68","article-title":"Thioredoxin and glutaredoxin-mediated redox regulation of ribonucleotide reductase","volume":"5","author":"Sengupta","year":"2014","journal-title":"World J. Biol. Chem"},{"key":"10.1074\/jbc.M117.783365_bib24","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.semcancer.2006.10.009","article-title":"The thioredoxin system in cancer","volume":"16","author":"Arn\u00e9r","year":"2006","journal-title":"Semin. Cancer Biol"},{"key":"10.1074\/jbc.M117.783365_bib25","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1089\/ars.2012.4757","article-title":"The thioredoxin system as a therapeutic target in human health and disease","volume":"19","author":"Mahmood","year":"2013","journal-title":"Antioxid. Redox Signal"},{"key":"10.1074\/jbc.M117.783365_bib26","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1089\/ars.2007.1957","article-title":"Redox regulation of cell survival","volume":"10","author":"Trachootham","year":"2008","journal-title":"Antioxid. Redox Signal"},{"key":"10.1074\/jbc.M117.783365_bib27","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ccell.2014.11.019","article-title":"Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progression","volume":"27","author":"Harris","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1074\/jbc.M117.783365_bib28","doi-asserted-by":"crossref","first-page":"33408","DOI":"10.1074\/jbc.M211107200","article-title":"Redox potential of human thioredoxin 1 and identification of a second dithiol\/disulfide motif","volume":"278","author":"Watson","year":"2003","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M117.783365_bib29","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1089\/ars.2005.7.823","article-title":"Thioredoxin and its related molecules: update 2005","volume":"7","author":"Nakamura","year":"2005","journal-title":"Antioxid. Redox Signal"},{"key":"10.1074\/jbc.M117.783365_bib30","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1089\/ars.2011.4322","article-title":"Thioredoxin and thioredoxin target proteins: from molecular mechanisms to functional significance","volume":"18","author":"Lee","year":"2013","journal-title":"Antioxid. Redox Signal"},{"key":"10.1074\/jbc.M117.783365_bib31","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1089\/ars.2011.4137","article-title":"Thioredoxin interacting protein: redox dependent and independent regulatory mechanisms","volume":"16","author":"Spindel","year":"2012","journal-title":"Antioxid. Redox Signal"},{"key":"10.1074\/jbc.M117.783365_bib32","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1089\/ars.2007.1529","article-title":"Thioredoxin1 as a negative regulator of cardiac hypertrophy","volume":"9","author":"Ago","year":"2007","journal-title":"Antioxid. Redox Signal"},{"key":"10.1074\/jbc.M117.783365_bib33","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s10620-012-2089-4","article-title":"The value of thioredoxin family proteins and proliferation markers in dysplastic and malignant gallbladders in patients with primary sclerosing cholangitis","volume":"57","author":"Said","year":"2012","journal-title":"Dig. Dis. Sci"},{"key":"10.1074\/jbc.M117.783365_bib34","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0891-5849(00)00313-0","article-title":"The role of the redox protein thioredoxin in cell growth and cancer","volume":"29","author":"Powis","year":"2000","journal-title":"Free Radic. Biol. Med"},{"key":"10.1074\/jbc.M117.783365_bib35","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.lab.2005.09.001","article-title":"The antitumor thioredoxin-1 inhibitor PX-12 (1-methylpropyl 2-imidazolyl disulfide) decreases thioredoxin-1 and VEGF levels in cancer patient plasma","volume":"147","author":"Baker","year":"2006","journal-title":"J. Lab. Clin. Med"},{"key":"10.1074\/jbc.M117.783365_bib36","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1158\/1078-0432.CCR-06-2250","article-title":"A Phase I pharmacokinetic and pharmacodynamic study of PX-12, a novel inhibitor of thioredoxin-1, in patients with advanced solid tumors","volume":"13","author":"Ramanathan","year":"2007","journal-title":"Clin. Cancer Res"},{"key":"10.1074\/jbc.M117.783365_bib37","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-14-3763","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"75","author":"Ashton","year":"2015","journal-title":"Cancer Res"},{"key":"10.1074\/jbc.M117.783365_bib38","doi-asserted-by":"crossref","first-page":"9813","DOI":"10.1073\/pnas.91.21.9813","article-title":"Two additional glutaredoxins exist in Escherichia coli: glutaredoxin 3 is a hydrogen donor for ribonucleotide reductase in a thioredoxin\/glutaredoxin 1 double mutant","volume":"91","author":"Aslund","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M117.783365_bib39","doi-asserted-by":"crossref","first-page":"8233","DOI":"10.1074\/jbc.M809338200","article-title":"Molecular mechanisms of thioredoxin and glutaredoxin as hydrogen donors for mammalian S phase ribonucleotide reductase","volume":"284","author":"Zahedi Avval","year":"2009","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M117.783365_bib40","doi-asserted-by":"crossref","first-page":"7439","DOI":"10.1073\/pnas.0401965101","article-title":"Interactions of glutaredoxins, ribonucleotide reductase, and components of the DNA replication system of Escherichia coli","volume":"101","author":"Ortenberg","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M117.783365_bib41","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1146\/annurev-genet-102108-134201","article-title":"Thioredoxins and glutaredoxins: unifying elements in redox biology","volume":"43","author":"Meyer","year":"2009","journal-title":"Annu. Rev. Genet"},{"key":"10.1074\/jbc.M117.783365_bib42","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1089\/ars.2006.8.735","article-title":"In vivo requirement for glutaredoxins and thioredoxins in the reduction of the ribonucleotide reductases of Escherichia coli","volume":"8","author":"Gon","year":"2006","journal-title":"Antioxid. Redox Signal"},{"key":"10.1074\/jbc.M117.783365_bib43","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/S0891-5849(01)00698-0","article-title":"Analysis of the inhibition of mammalian thioredoxin, thioredoxin reductase, and glutaredoxin by cis-diamminedichloroplatinum (II) and its major metabolite, the glutathione-platinum complex","volume":"31","author":"Arn\u00e9r","year":"2001","journal-title":"Free Radic. Biol. Med"},{"key":"10.1074\/jbc.M117.783365_bib44","doi-asserted-by":"crossref","first-page":"18044","DOI":"10.1074\/jbc.272.29.18044","article-title":"Characterization of Escherichia coli NrdH. A glutaredoxin-like protein with a thioredoxin-like activity profile","volume":"272","author":"Jordan","year":"1997","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M117.783365_bib45","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1126\/science.1190187","article-title":"Structural basis for activation of class Ib ribonucleotide reductase","volume":"329","author":"Boal","year":"2010","journal-title":"Science"},{"key":"10.1074\/jbc.M117.783365_bib46","doi-asserted-by":"crossref","first-page":"6259","DOI":"10.1074\/jbc.M113.533554","article-title":"Streptococcus sanguinis class Ib ribonucleotide reductase: high activity with both iron and manganese cofactors and structural insights","volume":"289","author":"Makhlynets","year":"2014","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M117.783365_bib47","doi-asserted-by":"crossref","first-page":"9001","DOI":"10.1021\/ja5030194","article-title":"A chemically competent thiosulfuranyl radical on the Escherichia coli class III ribonucleotide reductase","volume":"136","author":"Wei","year":"2014","journal-title":"J. Am. Chem. Soc"},{"key":"10.1074\/jbc.M117.783365_bib48","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1021\/acs.biochem.5b01207","article-title":"Allosteric inhibition of human ribonucleotide reductase by dATP entails the stabilization of a hexamer","volume":"55","author":"Ando","year":"2016","journal-title":"Biochemistry"},{"key":"10.1074\/jbc.M117.783365_bib49","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1042\/BJ20120075","article-title":"Redox properties of the disulfide bond of human Cu, Zn superoxide dismutase and the effects of human glutaredoxin 1","volume":"446","author":"Bouldin","year":"2012","journal-title":"Biochem. J"},{"key":"10.1074\/jbc.M117.783365_bib50","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1126\/science.1251550","article-title":"Enzyme regulation. IRBIT is a novel regulator of ribonucleotide reductase in higher eukaryotes","volume":"345","author":"Arnaoutov","year":"2014","journal-title":"Science"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820427139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820427139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.M117.783365","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T12:09:17Z","timestamp":1641298157000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820427139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":50,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0021925820427139"],"URL":"https:\/\/doi.org\/10.1074\/jbc.m117.783365","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Physical interaction between human ribonucleotide reductase large subunit and thioredoxin increases colorectal cancer malignancy","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.M117.783365","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}]}}